B
Barry R. Davis
Researcher at University of Texas at Austin
Publications - 351
Citations - 50989
Barry R. Davis is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Chlorthalidone & Amlodipine. The author has an hindex of 78, co-authored 342 publications receiving 47899 citations. Previous affiliations of Barry R. Davis include Tulane University & Cardiovascular Institute of the South.
Papers
More filters
Journal ArticleDOI
Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?
Richard H. Grimm,Barry R. Davis,Linda B. Piller,Jeffrey A. Cutler,Karen L. Margolis,Joshua I. Barzilay,Richard A. Dart,James F. Graumlich,Robert A. Murden,Otelio S. Randall +9 more
TL;DR: No significant evidence was found that pre‐entry drug type explained observed hospitalized HF differences by ALLHAT treatment, and interactive effects of previous medication and ALLHat treatment on HF outcomes were examined.
Journal ArticleDOI
Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT
Jose-Miguel Yamal,Suzanne Oparil,Barry R. Davis,Michael H. Alderman,David A. Calhoun,William C. Cushman,Herbert F. Fendley,Stanley S. Franklin,Gabriel B. Habib,Sara L. Pressel,Jeffrey L. Probstfield,Sithiporn Sastrasinh +11 more
TL;DR: The AllHAT trial as mentioned in this paper compared cardiovascular disease outcomes in participants initially treated with an angiotensin-converting enzyme inhibitor (lisinopril), a calcium channel blocker (amlodipine), or a thiazide-type diuretic (chlorthalidone), for a total follow-up of 8-13 years.
Journal Article
Effect of weight loss on thiazide produced erectile problems in men.
Herbert G. Langford,Robin W. Rockhold,S. Wassertheil-Smoller,A. Oberman,Barry R. Davis,M. D. Blaufox +5 more
TL;DR: Thiazide-type diuretics frequently produce erectile dysfunction in men on a regular diet but on a weight-loss diet, the mechanism of the dysfunction and the favorable response to weight loss is unknown.
Journal ArticleDOI
The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study.
Anh N. Do,Amy I. Lynch,Steven A. Claas,Eric Boerwinkle,Barry R. Davis,Charles E. Ford,John H. Eckfeldt,Hemant K. Tiwari,Donna K. Arnett,Marguerite R. Irvin +9 more
TL;DR: Whether variants in 35 candidate genes might modulate BP response to four different antihypertensive medications, including an angiotensin-converting enzyme inhibitor, a calcium channel blocker, and an a-adrenergic blocker as compared with a thiazide diuretic after 6 months of follow-up is examined.
Journal Article
Abstract 2734: Heart Failure with Preserved and Impaired Left Ventricular Systolic Function in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Barry R. Davis,Lara M. Simpson,Henry R. Black,Willilam C Cushman,Paula T. Einhorn,Michael A. Farber,Charles E. Ford,Daniel Levy,Barry M. Massie,S. Nawaz +9 more